Case T-251/03: Judgment of the Court of First Instance (Fifth Chamber) of  31 January 2006  — Albrecht and Others v Commission (Health policy — Veterinary medicinal products — Products containing benzathine benzylpenicillin — Commission decision ordering suspension of marketing authorisations — Competence)
Date: 2006-04-08
Institutions: Court of First Instance
Subjects: European Commission, action for annulment (EU), antibiotic, veterinary drug, withdrawal from the market

C 86/24

EN

Official Journal of the European Union

8.4.2006

COURT OF FIRST INSTANCE

Judgment of the Court of First Instance of 7 February
2006 — Alecansan v OHIM

3. Orders the intervener to pay its own costs.

(Case T-202/03) (1)

(1) OJ C 184, 2.8.2003.

(Community trade mark — Opposition proceedings — Appli-
cation for the figurative Community trade mark COMP USA
— Earlier national figurative mark COMP USA — Lack of
similarity of the goods and services — Rejection of the oppo-
sition — Article 8(1)(b) of Regulation (EC) No 40/94)

(2006/C 86/46)

Language of the case: English

Parties

Judgment of the Court of First Instance (Fifth Chamber) of
31 January 2006 — Albrecht and Others v Commission

(Case T-251/03) (1)

(Health policy — Veterinary medicinal products — Products
containing benzathine benzylpenicillin — Commission deci-
sion ordering suspension of marketing authorisations —
Competence)

Applicant: Alecansan, SL (Madrid, Spain)
(represented by: M.
Baylos Morales, P. Merino Baylos, J. Arribas García, A. Veláz-
quez Ibáñez and A. Angulo Lafora, lawyers)

(2006/C 86/47)

Language of the case: English

Defendant: Office for Harmonisation in the Internal Market
(Trade Marks and Designs) (represented by: D. Botis and A.
Folliard-Monguiral, Agents)

Parties

Other party or parties to the proceedings before the Board of
Appeal of OHIM intervening before the Court of First Instance:
CompUSA Management Co. (Dallas, United States) (represented
by: P. Brownlow, Solicitor)

Action

brought against the decision of the First Board of Appeal of
OHIM of 24 March 2003 (Case R 711/2002-1) relating to the
opposition proceedings between Alecansan, SL, and CompUSA
Management Co.

Operative part of the judgment

The Court:

1. Dismisses the action;

2. Orders the applicant to pay its own costs and those of the Office
(Trade Marks and

for Harmonisation in the Internal Market
Designs);

Applicants: Albert Albrecht GmbH & Co. KG,
(Aulendorf,
Germany), AniMedica GmbH (Seden-Bösensell, Germany), Ceva
Tiergensundheit GmbH (Düsseldorf, Germany), Fatro SpA
(Bologna, Italy), Laboratorios Syva, SA (León, Spain), Labora-
torios Virbac, SA (Barcelona, Spain), Química Farmacéutica
Bayer, SA (Barcelona), Univete Técnica Pecuaria Comercio
Industria, Lda (Lisbon, Portugal), Vétoquinol Especialidades
Veterinarias, SA (Madrid, Spain), Virbac SA (Carros, France),
(represented by: D. Waelbroeck, U. Zinsmeister and N. Rampal,
lawyers)

Defendant(s): Commission of the European Communities (repre-
sented by: H. Støvlbæk and M. Shotter, Agents)

Intervener(s) in support of the applicant(s): French Republic (repre-
sented by: G. de Bergues and R. Loosli-Surrans, Agents)

Application for

annulment of Commission Decision C(2003) 1404 of 22 April
2003 ordering suspension of the marketing authorisations of
veterinary medicinal products containing benzathine benzylpe-
nicillin intended to be administered by intramuscular and/or
subcutaneous means to food-producing animals,

8.4.2006

EN

Official Journal of the European Union

C 86/25

Operative part of the judgment

The Court:

1. Annuls Commission Decision C(2003) 1404 of 22 April 2003
ordering suspension of the marketing authorisations of veterinary
medicinal products containing benzathine benzylpenicillin intended
to be administered by intramuscular and/or subcutaneous means
to food-producing animals;

2. Orders the Commission to bear its own costs and those incurred

by the applicants;

3. Orders the French Republic to bear its own costs.

(1) OJ C 239, 4.10.2003.

Judgment of the Court of First Instance (Fifth Chamber) of
31 January 2006 — Merck Sharp & Dohme and Others v
Commission

(Case T-273/03) (1)

(Medicinal products for human use — Marketing authorisa-
tion for products containing the substance enalapril —
Commission decision ordering amendment of the summary of
the product's characteristics — Competence)

(2006/C 86/48)

Language of the case: English

1. Annuls Commission Decision C(2003) 1752 of 21 May 2003
on the marketing of medicinal products for human use containing
the substance enalapril;

2. Orders the Commission to pay the costs.

(1) OJ C 251, 18.10.2003.

Judgment of the Court of First Instance of 31 January
2006 — Giulietti v Commission

(Case T-293/03) (1)

(Officials — Open competition — Exclusion from the compe-
tition — Illegality of the competition notice — Inadmissi-
bility — Professional experience — Full-time activity)

(2006/C 86/49)

Language of the case: French

Parties

Applicant: Carla Giulietti (Brussels, Belgium) (represented by: P.-
P. Van Gehuchten, J. Sambon and P.Reyniers, lawyers)

Defendant: Commission of the European Communities (repre-
sented by: G. Berscheid and C. Berardis-Kayser, Agents)

Parties

Application for

Applicant(s): Merck Sharp & Dohme Ltd (Hoddesdon, United
Kingdom), Merck Sharp & Dohme BV (Haarlem, Netherlands),
Laboratoires Merck Sharp & Dohme-Chibret
(Paris, France),
MSD Sharp & Dohme GmbH (Haar, Germany), Merck Sharp &
Dohme (Italia) SpA (Rome, Italy), Merck Sharp & Dohme, Lda
(Paço de Arcos, Portugal), Merck Sharp & Dohme de España,
SA (Madrid, Spain), Merck Sharp & Dohme GmbH (Vienna,
Austria), Vianex SA (Nea Erythrea, Greece), (represented by: G.
Berrisch and P. Bogaert, lawyers)

Annulment, firstly, of the decision of the selection board for
competition COM/A/6/01 to exclude the applicant from that
competition on the ground of lack of professional experience,
communicated by letter of 16 October 2002; secondly, of the
confirmatory decision of that selection board,
following an
application for reconsideration submitted by the applicant,
communicated by letter of 21 November 2002, and, thirdly, of
the express decision rejecting the complaint of 11 June 2003.

Defendant: Commission of the European Communities (repre-
sented by: L. Flynn and B. Stromsky, Agents)

Operative part of the judgment

Action for

annulment of Commission Decision C(2003) 1752 of 21 May
2003 on the marketing of medicinal products for human use
containing the substance enalapril

Operative part of the judgment

The Court:

The Court:

1. Dismisses the action.

2. Orders each party to bear its own costs.

(1) OJ C 251, 18.10.2003